Transparency and integrity: Cochrane news and activities | Cochrane Community

Following the launch of the new cochrane.org website, we are working on restructuring the Community site.
Until this work is finished, some content you find here may still be relevant but some may be outdated.
To find still published content on this site, use the Search box above.

Latest news from Cochrane

Cochrane's statement to the 74th World Health Assembly (1 June 2021)
Cochrane shows support for WHO-ICMRA statement on transparency and data integrity (7 May 2021)
Cochrane signs letter asking medicines regulators in Europe to address unpublished clinical trials (10 May 2021)
New independent study finds Cochrane’s transparency over reporting financial conflicts of interest is leading the way 20 May 2020
Cochrane Centres call for transparency of COVID-19 clinical studies 20 May 2020
Cochrane's statement to the 73rd World Health Assembly 18 May 2020
Cochrane’s statement in support of EMA’s clinical study report transparency policy 13 January 2020
BMJ blog: Karla Soares-Weiser: Cochrane announces a new, more rigorous “conflict of interest” policy 3 December 2019
Cochrane supports AllTrials report on UK clinical trial transparency used as a basis for parliament evidence session 8 November 2019
Cochrane advocates for clinical trial transparency at EU Parliament event 25 October 2019
2019 Cochrane-REWARD Prize winners announced 18 October 2019
Cochrane CSR Working Group’s open letter in response to the FDA’s public comment request on the Clinical Data Summary Report Pilot 22 August 2019
Cochrane supports European regulators as they urge clinical trial sponsors to share their results 10 July 2019

Resources and activities from Cochrane Groups